tirzepatide and colonoscopy Prep on Zepbound Warning Had to STOP my GLP1
Description
The move comes after the FDA approved Wegovy (semaglutide) for weight management in adults in 2021
We know how excited people are about the weight loss that can come from these new medications, including people trying to conceive
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, currently unapproved by the MHRA, EMA, or FDA for routine clinical use
Dig Dis Sci 2009;54:24042409
To understand your surgeon's caution, it helps to know about two key concepts: delayed gastric emptying and aspiration risk
GLP-1s weight loss is a weight loss program designed around the GLP-1s medication
